The store will not work correctly when cookies are disabled.
1-(4-chlorophenyl)-3-(3-(4-fluorophenoxy)propyl)guanidine
ID: ALA4084182
PubChem CID: 72950698
Max Phase: Preclinical
Molecular Formula: C16H17ClFN3O
Molecular Weight: 321.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(NCCCOc1ccc(F)cc1)Nc1ccc(Cl)cc1
Standard InChI: InChI=1S/C16H17ClFN3O/c17-12-2-6-14(7-3-12)21-16(19)20-10-1-11-22-15-8-4-13(18)5-9-15/h2-9H,1,10-11H2,(H3,19,20,21)
Standard InChI Key: YIXQZLPGNXXTFM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
29.9711 -7.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6855 -7.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2565 -7.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5466 -7.5303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4000 -7.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1145 -7.1167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8289 -7.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8266 -8.3553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5403 -8.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2556 -8.3551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2530 -7.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5389 -7.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9707 -8.7667 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.8305 -7.1205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5498 -8.3552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1176 -7.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4046 -7.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6921 -7.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6950 -8.3641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4160 -8.7736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1254 -8.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9826 -8.7803 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
3 4 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
10 13 1 0
4 14 1 0
4 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.78 | Molecular Weight (Monoisotopic): 321.1044 | AlogP: 3.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 57.14 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.15 | CX LogP: 3.68 | CX LogD: 1.43 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.43 | Np Likeness Score: -1.32 |
References
1. Salvino JM, Srikanth YVV, Lou R, Oyer HM, Chen N, Kim FJ.. (2017) Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer., 27 (10): [PMID:28385503] [10.1016/j.bmcl.2017.03.030] |